Anlon Healthcare Limited Acquires Majority Stake in Bizotic Life Science Private Limited
Anlon Healthcare Limited has completed the acquisition of a 56.67% equity stake in Bizotic Life Science Private Limited, effective March 20, 2026. This acquisition transforms Bizotic Life Science Private Limited into a subsidiary of Anlon Healthcare Limited.The acquisition follows a Share Purchase Agreement initially dated November 28, 2025, and an amendment agreement executed on February 27, 2026, which extended the completion timeframe to March 20, 2026.
Previous disclosures regarding this transaction were made on November 28, 2025, and February 27, 2026, and detailed information pertaining to the acquisition is included in those earlier announcements. The investment adheres to Section 179 (3) (e) & (j) and other relevant provisions of the Companies Act, 2013.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.